A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis

BACKGROUND: Amphotericin B deoxycholate (AmB-D) is standard of care treatment for neonatal invasive candidiasis (IC). Micafungin (MCA) has broad-spectrum fungicidal activity against Candida spp. We compared the efficacy and safety of intravenous MCA with intravenous AmB-D and assessed the pharmacoki...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pediatr Infect Dis J
Autori principali: Benjamin, Daniel K., Kaufman, David A., Hope, William W., Smith, P. Brian, Arrieta, Antonio, Manzoni, Paolo, Kovanda, Laura L., Lademacher, Christopher, Isaacson, Brigit, Jednachowski, Deborah, Wu, Chunzhang, Kaibara, Atsunori, Walsh, Thomas J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Williams & Wilkins 2018
Soggetti:
Antimicrobial Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6155365/
https://ncbi.nlm.nih.gov/pubmed/29596222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001996
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi